{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:52:24Z","timestamp":1792324344725,"version":"4.4.0"},"reference-count":209,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Cannabidiol (CBD) is a naturally occurring non-psychoactive cannabinoid found in <jats:italic>Cannabis sativa<\/jats:italic>, commonly known as cannabis or hemp. Although currently available CBD products do not meet the safety standards of most food safety authorities to be approved as a dietary supplement or food additive, CBD has been gaining widespread attention in recent years due to its various potential health benefits. While primarily known for its therapeutic effects in managing epileptic seizures, psychosis, anxiety, (neuropathic) pain, and inflammation, CBD\u2019s influence on brain function has also piqued the interest of researchers and individuals seeking to enhance cognitive performance. The primary objective of this review is to gather, synthesize, and consolidate scientifically proven evidence on the impact of CBD on brain function and its therapeutic significance in treating neurological and mental disorders. First, basic background information on CBD, including its biomolecular properties and mechanisms of action is presented. Next, evidence for CBD effects in the human brain is provided followed by a discussion on the potential implications of CBD as a neurotherapeutic agent. The potential effectiveness of CBD in reducing chronic pain is considered but also in reducing the symptoms of various brain disorders such as epilepsy, Alzheimer\u2019s, Huntington\u2019s and Parkinson\u2019s disease. Additionally, the implications of using CBD to manage psychiatric conditions such as psychosis, anxiety and fear, depression, and substance use disorders are explored. An overview of the beneficial effects of CBD on aspects of human behavior, such as sleep, motor control, cognition and memory, is then provided. As CBD products remain largely unregulated, it is crucial to address the ethical concerns associated with their use, including product quality, consistency, and safety. Therefore, this review discusses the need for responsible research and regulation of CBD to ensure its safety and efficacy as a therapeutic agent for brain disorders or to stimulate behavioral and cognitive abilities of healthy individuals.<\/jats:p>","DOI":"10.3389\/fphar.2023.1328885","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T04:11:28Z","timestamp":1705291888000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Cannabidiol and brain function: current knowledge and future perspectives"],"prefix":"10.3389","volume":"14","author":[{"given":"Moniek","family":"Schouten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Mantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Koppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biology10060542","article-title":"Potential and limits of cannabinoids in Alzheimer\u2019s disease therapy","volume":"10","author":"Abate","year":"2021","journal-title":"Biology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2020.00561","article-title":"A balanced approach for cannabidiol use in chronic pain","volume":"11","author":"Argueta","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"106996","DOI":"10.1016\/j.eplepsyres.2022.106996","article-title":"Quantitative electroencephalographic analysis as a potential biomarker of response to treatment with cannabidiol","volume":"185","author":"Armstrong","year":"2022","journal-title":"Epilepsy Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/j.1476-5381.2010.01179.x","article-title":"Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice","volume":"162","author":"Avraham","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.1523\/JNEUROSCI.2134-04.2004","article-title":"Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling","volume":"24","author":"Azad","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/cr.2011.60","article-title":"GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils","volume":"21","author":"Balenga","year":"2011","journal-title":"Cell Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2012.09.053","article-title":"Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis","volume":"697","author":"Barichello","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"618184","DOI":"10.3389\/fphar.2020.618184","article-title":"The impact of cannabidiol on human brain function: a systematic review","volume":"11","author":"Batalla","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fphar.2019.00352","article-title":"Oral cannabidiol prevents allodynia and neurological dysfunctions in a mouse model of mild traumatic brain injury","volume":"10","author":"Belardo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2018.2309","article-title":"Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial","volume":"75","author":"Bhattacharyya","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/epi.16093","article-title":"Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy","volume":"60","author":"Birnbaum","year":"2019","journal-title":"Epilepsia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/0269881120936419","article-title":"The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: an arterial spin labelling magnetic resonance imaging study","volume":"34","author":"Bloomfield","year":"2020","journal-title":"J. Psychopharmacol. (Oxf)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacol. Berl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.tips.2006.10.008","article-title":"Adenosine kinase, epilepsy and stroke: mechanisms and therapies","volume":"27","author":"Boison","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacol. Berl."},{"key":"B22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuroscience.2014.12.051","article-title":"Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria","volume":"289","author":"Campos","year":"2015","journal-title":"Neuroscience"},{"key":"B23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2017.00269","article-title":"Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders","volume":"8","author":"Campos","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/1073858412469444","article-title":"Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?","volume":"19","author":"Carlino","year":"2013","journal-title":"Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1186\/s12889-022-14057-0","article-title":"Cannabidiol use and perceptions in France: a national survey","volume":"22","author":"Casanova","year":"2022","journal-title":"BMC Public Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2010.06.023","article-title":"Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture","volume":"1348","author":"Cassol","year":"2010","journal-title":"Brain Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/hipo.22566","article-title":"Abnormal hippocampal structure and function in clinical anxiety and comorbid depression","volume":"26","author":"Cha","year":"2016","journal-title":"Hippocampus"},{"key":"B31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson\u2019s disease patients: a case series","volume":"39","author":"Chagas","year":"","journal-title":"J. Clin. Pharm. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: an exploratory double-blind trial","volume":"28","author":"Chagas","year":"","journal-title":"J. Psychopharmacol. Oxf Engl."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7812\/TPP\/19.200","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon","year":"2020","journal-title":"Perm. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u2206E9 mice","volume":"231","author":"Cheng","year":"","journal-title":"Psychopharmacol. Berl."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer\u2019s disease transgenic mice","volume":"42","author":"Cheng","year":"","journal-title":"J. Alzheimers Dis. Jad."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet Lond Engl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"587604","DOI":"10.3389\/fphar.2020.587604","article-title":"Medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of APP<i>Swe<\/i>\/PS1\u0394E9 transgenic female mice","volume":"11","author":"Coles","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-g","article-title":"Controlled clinical trial of cannabidiol in Huntington\u2019s disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/ph15050495","article-title":"Antiseizure effects of cannabidiol leading to increased peroxisome proliferator-activated receptor gamma levels in the hippocampal CA3 subfield of epileptic rats","volume":"15","author":"Costa","year":"2022","journal-title":"Pharm. Basel Switz."},{"key":"B41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation","volume":"143","author":"Costa","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol. (Oxf)."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.transproceed.2017.12.042","article-title":"Chronic pain treatment with cannabidiol in kidney transplant patients in Uruguay","volume":"50","author":"Cu\u00f1etti","year":"2018","journal-title":"Transpl. Proc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/mds.22809","article-title":"A pilot study using nabilone for symptomatic treatment in Huntington\u2019s disease","volume":"24","author":"Curtis","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1007\/s11064-023-03905-z","article-title":"Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or \u03b1-synuclein in Caenorhabditis elegans","volume":"48","author":"da Cruz Guedes","year":"2023","journal-title":"Neurochem. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00213-012-2955-y","article-title":"Cannabidiol enhances consolidation of explicit fear extinction in humans","volume":"226","author":"Das","year":"2013","journal-title":"Psychopharmacol. Berl."},{"key":"B50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2015.03.051","article-title":"Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: the role of CB1-cannabinoid receptor in the ventral mesencephalon","volume":"758","author":"da Silva","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.01.014","article-title":"Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol","volume":"139","author":"da Silva","year":"2018","journal-title":"Brain Res. Bull."},{"key":"B52","doi-asserted-by":"publisher","first-page":"109330","DOI":"10.1016\/j.yebeh.2023.109330","article-title":"The use of cannabinoids in children with epilepsy: a systematic review","volume":"145","author":"da Silva Rodrigues","year":"2023","journal-title":"Epilepsy Behav. EB"},{"key":"B53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/can.2021.0158","article-title":"The effect of cannabidiol for restless Legs syndrome\/willis-ekbom disease in Parkinson\u2019s disease patients with REM sleep behavior disorder: a post hoc exploratory analysis of phase 2\/3 clinical trial","volume":"8","author":"de Almeida","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/adb.12366","article-title":"Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats","volume":"22","author":"de Carvalho","year":"2017","journal-title":"Addict. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0269881119895536","article-title":"Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson\u2019s disease","volume":"34","author":"de Faria","year":"2020","journal-title":"J. Psychopharmacol. Oxf Engl."},{"key":"B56","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism","volume":"23","author":"Di","year":"2003","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1073858411431646","article-title":"Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics","volume":"18","author":"Dincheva","year":"2012","journal-title":"Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J. Psychopharmacol. Oxf Engl."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e28668","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces a\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS ONE"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00213-011-2449-3","article-title":"Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders","volume":"219","author":"Fagherazzi","year":"2012","journal-title":"Psychopharmacol. Berl."},{"key":"B66","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"114433","DOI":"10.1016\/j.bcp.2021.114433","article-title":"Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: modulation of inflammatory pathways","volume":"185","author":"Florensa-Zanuy","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1503\/jpn.110021","article-title":"Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis","volume":"37","author":"Fusar-Poli","year":"2012","journal-title":"J. Psychiatry Neurosci. Jpn."},{"key":"B70","doi-asserted-by":"publisher","first-page":"107740","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms","volume":"167","author":"Galaj","year":"2020","journal-title":"Neuropharmacology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"pyu026","DOI":"10.1093\/ijnp\/pyu026","article-title":"PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation","volume":"18","author":"Gazarini","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacol. Berl."},{"key":"B75","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/can.2020.0093","article-title":"Use and perceptions of cannabidiol products in Canada and in the United States","volume":"7","author":"Goodman","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s0306-4522(02)00034-9","article-title":"GABA mechanisms and sleep","volume":"111","author":"Gottesmann","year":"2002","journal-title":"Neuroscience"},{"key":"B77","doi-asserted-by":"publisher","first-page":"108190","DOI":"10.1016\/j.yebeh.2021.108190","article-title":"Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy","volume":"122","author":"Grayson","year":"2021","journal-title":"Epilepsy Behav. EB"},{"key":"B78","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.euroneuro.2018.04.004","article-title":"Probing the endocannabinoid system in healthy volunteers: cannabidiol alters fronto-striatal resting-state connectivity","volume":"28","author":"Grimm","year":"2018","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacol. Berl."},{"key":"B80","doi-asserted-by":"publisher","first-page":"bjgpopen20X101010","DOI":"10.3399\/bjgpopen20X101010","article-title":"Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand","volume":"4","author":"Gulbransen","year":"2020","journal-title":"BJGP Open"},{"key":"B81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/s1516-44462010000100011","article-title":"Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)","volume":"32","author":"Hallak","year":"2010","journal-title":"Rev. Bras. Psiquiatr. Sao Paulo Braz"},{"key":"B82","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.conb.2008.08.007","article-title":"Wiring and firing neuronal networks: endocannabinoids take center stage","volume":"18","author":"Harkany","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S109285292000200X","article-title":"Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice","volume":"27","author":"Hauser","year":"2022","journal-title":"CNS Spectr."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e6312","DOI":"10.7759\/cureus.6312","article-title":"Cannabidiol (CBD) for treatment of neurofibromatosis-related pain and concomitant mood disorder: a case report","volume":"11","author":"Hegazy","year":"2019","journal-title":"Cureus"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10787-022-01020-z","article-title":"Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions","volume":"30","author":"Henson","year":"2022","journal-title":"Inflammopharmacology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainres.2009.12.020","article-title":"Resting hippocampal blood flow, spatial memory and aging","volume":"1315","author":"Heo","year":"2010","journal-title":"Brain Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"108558","DOI":"10.1016\/j.yebeh.2022.108558","article-title":"Electroencephalographic changes in purified pharmaceutical cannabidiol therapy","volume":"128","author":"Herlopian","year":"2022","journal-title":"Epilepsy Behav. EB"},{"key":"B88","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.euroneuro.2014.11.014","article-title":"Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users","volume":"25","author":"Hindocha","year":"2015","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/ncomms2270","article-title":"PPAR\u03b3 is an E3 ligase that induces the degradation of NF\u03baB\/p65","volume":"3","author":"Hou","year":"2012","journal-title":"Nat. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2011.08.013","article-title":"Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats","volume":"62","author":"Hsiao","year":"2012","journal-title":"Neuropharmacology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1038\/s41467-023-39307-6","article-title":"Cannabidiol inhibits Nav channels through two distinct binding sites","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"B92","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s13311-015-0373-7","article-title":"Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage","volume":"12","author":"Hurd","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2019.03.014","article-title":"Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors","volume":"1715","author":"Jesus","year":"2019","journal-title":"Brain Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.seizure.2010.12.002","article-title":"WITHDRAWN: cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures","volume":"21","author":"Jones","year":"2012","journal-title":"Seizure"},{"key":"B95","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fphar.2016.00454","article-title":"Cannabidiol regulation of learned fear: implications for treating anxiety-related disorders","volume":"7","author":"Jurkus","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnmol.2020.00041","article-title":"Oxidative stress in cognitive and epigenetic aging: a retrospective glance","volume":"13","author":"Kandlur","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.3390\/ijms22115431","article-title":"Neuroprotective and immunomodulatory action of the endocannabinoid system under neuroinflammation","volume":"22","author":"Kasatkina","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s11064-017-2287-8","article-title":"Evaluation of cannabidiol in animal seizure models by the epilepsy therapy screening program (ETSP)","volume":"42","author":"Klein","year":"2017","journal-title":"Neurochem. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1088459","DOI":"10.3389\/fpsyt.2023.1088459","article-title":"Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: a case report in a clinically high-risk mental state","volume":"14","author":"Koethe","year":"2023","journal-title":"Front. Psychiatry"},{"key":"B101","doi-asserted-by":"publisher","first-page":"CD004044","DOI":"10.1002\/14651858.CD004044.pub5","article-title":"Pharmacological treatment for psychotic depression","volume":"12","author":"Kruizinga","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"B102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/sleep\/22.1.33","article-title":"Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists","volume":"22","author":"Lancel","year":"1999","journal-title":"Sleep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/14737175.2021.1834383","article-title":"Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome","volume":"21","author":"Lattanzi","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/can.2019.0068","article-title":"Safety and tolerability of cannabidiol in Parkinson disease: an open label, dose-escalation study","volume":"5","author":"Leehey","year":"2020","journal-title":"Cannabis Cannabinoid Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000521683","article-title":"Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals","volume":"107","author":"Legare","year":"2022","journal-title":"Pharmacology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"106720","DOI":"10.1016\/j.yebeh.2019.106720","article-title":"Epidemiology of status epilepticus in adults: apples, pears, and oranges - a critical review","volume":"103","author":"Leitinger","year":"2020","journal-title":"Epilepsy Behav. EB"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"B110","doi-asserted-by":"publisher","first-page":"614811","DOI":"10.3389\/fphar.2021.614811","article-title":"Cannabidiol and amisulpride improve cognition in acute schizophrenia in an explorative, double-blind, active-controlled, randomized clinical trial","volume":"12","author":"Leweke","year":"2021","journal-title":"Randomized Clin. Trial. Front. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5024520","DOI":"10.1155\/2018\/5024520","article-title":"Neural basis of depression related to a dominant right hemisphere: a resting-state fMRI study","volume":"2018","author":"Li","year":"2018","journal-title":"Behav. Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/ijms18010026","article-title":"Cannabidiol modulates the expression of Alzheimer\u2019s disease-related genes in mesenchymal stem cells","volume":"18","author":"Libro","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-2982.2011.01742.x","article-title":"A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents","volume":"23","author":"Lin","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Rev. Bras. Psiquiatr. Sao Paulo Braz"},{"key":"B115","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fphar.2018.00315","article-title":"No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study","volume":"9","author":"Linares","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s00415-016-8145-9","article-title":"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington\u2019s disease","volume":"263","author":"L\u00f3pez-Send\u00f3n Moreno","year":"2016","journal-title":"J. Neurol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"105014","DOI":"10.1016\/j.neubiorev.2022.105014","article-title":"Effects of cannabinoids on resting state functional brain connectivity: a systematic review","volume":"145","author":"Lorenzetti","year":"2023","journal-title":"Neurosci. Biobehav Rev."},{"key":"B119","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"B120","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41586-019-0978-9","article-title":"Complete biosynthesis of cannabinoids and their unnatural analogues in yeast","volume":"567","author":"Luo","year":"2019","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1038\/s41467-023-42416-x","article-title":"Ligand activation mechanisms of human KCNQ2 channel","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"B122","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","article-title":"Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation","volume":"51","author":"Magen","year":"2009","journal-title":"J. Hepatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.brainresbull.2021.06.017","article-title":"Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: the role of medial prefrontal cortex 5-HT1A and CB1 receptors","volume":"174","author":"Malvestio","year":"2021","journal-title":"Brain Res. Bull."},{"key":"B125","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"B126","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B128","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"B129","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/brain\/awh109","article-title":"5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study","volume":"127","author":"Merlet","year":"2004","journal-title":"Brain J. Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42238-021-00061-5","article-title":"Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems","volume":"3","author":"Moltke","year":"2021","journal-title":"J. Cannabis Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1037\/pha0000635","article-title":"Effects of oral \u03949-tetrahydrocannabinol and cannabidiol combinations on a sustained attention task in rats","volume":"31","author":"Moore","year":"2023","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B134","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41398-018-0191-x","article-title":"Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function","volume":"8","author":"Morgan","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/ejn.15134","article-title":"Differential contribution of CB1, CB2, 5-HT1A, and PPAR-\u03b3 receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments","volume":"53","author":"Mori","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1016\/j.febslet.2006.04.102","article-title":"Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats","volume":"580","author":"Murillo-Rodr\u00edguez","year":"2006","journal-title":"FEBS Lett."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1037\/a0013278","article-title":"The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent","volume":"122","author":"Murillo-Rodr\u00edguez","year":"2008","journal-title":"Behav. Neurosci."},{"key":"B139","doi-asserted-by":"publisher","first-page":"626010","DOI":"10.3389\/fphar.2021.626010","article-title":"Role of cannabidiol in the therapeutic intervention for substance use disorders","volume":"12","author":"Navarrete","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1017\/S0033291719003519","article-title":"Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis","volume":"51","author":"O'Neill","year":"2021","journal-title":"Psychol. Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacol. Berl."},{"key":"B143","doi-asserted-by":"publisher","first-page":"107360","DOI":"10.1016\/j.addbeh.2022.107360","article-title":"Cannabidiol in the context of substance use disorder treatment: a systematic review","volume":"132","author":"Paulus","year":"2022","journal-title":"Addict. Behav."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e0152473","DOI":"10.1371\/journal.pone.0152473","article-title":"Endocannabinoid signaling regulates sleep stability","volume":"11","author":"Pava","year":"2016","journal-title":"PLOS ONE"},{"key":"B145","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fphar.2016.00343","article-title":"Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats","volume":"7","author":"Peres","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1055\/s-0040-1714329","article-title":"Effect of cannabinoids on electroencephalography of a child with lennox-gastaut syndrome","volume":"11","author":"Prakash","year":"2020","journal-title":"J. Neurosci. Rural. Pract."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41386-019-0333-8","article-title":"Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder","volume":"44","author":"Pretzsch","year":"2019","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2017.12.001","article-title":"Suppression of autophagy in the brain of transgenic mice with overexpression of \u041053\u0422-mutant \u03b1-synuclein as an early event at synucleinopathy progression","volume":"672","author":"Pupyshev","year":"2018","journal-title":"Neurosci. Lett."},{"key":"B152","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"36","author":"Renard","year":"2016","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1601-5215.2011.00579.x","article-title":"Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala","volume":"23","author":"R\u00e9us","year":"2011","journal-title":"Acta Neuropsychiatr."},{"key":"B156","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/3-540-26573-2_15","article-title":"Cannabinoid function in learning, memory and plasticity","volume":"168","author":"Riedel","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5214\/ans.0972.7531.210308","article-title":"The mechanism of degeneration of striatal neuronal subtypes in Huntington disease","volume":"21","author":"Rikani","year":"2014","journal-title":"Ann. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1196\/annals.1296.041","article-title":"5-HT1A receptor activation before acute stress counteracted the induced long-term behavioral effects","volume":"1018","author":"Rioja","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/fcp.12868","article-title":"The effects of cannabidiol on subjective states, cognition, and psychomotor function in healthy adults: a randomized clinical trial","volume":"37","author":"Rudisill","year":"2023","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","article-title":"Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels","volume":"29","author":"Ryan","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/cancers11030322","article-title":"The transient receptor potential vanilloid type-2(TRPV2) ion channels in neurogenesis andGliomagenesis: cross-talk between TranscriptionFactors and signaling molecules","volume":"11","author":"Santoni","year":"2019","journal-title":"Cancers"},{"key":"B164","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B166","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12640-014-9457-0","article-title":"Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice","volume":"26","author":"Schiavon","year":"2014","journal-title":"Neurotox. Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2147\/JPR.S278718","article-title":"Cannabidiol as a treatment for chronic pain: a survey of patients\u2019 perspectives and attitudes","volume":"14","author":"Schilling","year":"2021","journal-title":"J. Pain Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnbeh.2019.00094","article-title":"Prolonged cannabidiol treatment lacks on detrimental effects on memory, motor performance and anxiety in C57bl\/6J mice","volume":"13","author":"Schleicher","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1089\/can.2022.0220","article-title":"Molecular mechanisms through which cannabidiol may affect skeletal muscle metabolism, inflammation, tissue regeneration, and anabolism: a narrative review","volume":"7","author":"Schouten","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res. PTR"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e920","DOI":"10.1038\/tp.2016.195","article-title":"Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose","volume":"6","author":"Seeman","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"B172","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm. J."},{"key":"B173","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000443890","article-title":"Prohedonic effect of cannabidiol in a rat model of depression","volume":"73","author":"Shoval","year":"2016","journal-title":"Neuropsychobiology"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1590\/1806-9282.2022D689","article-title":"Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex","volume":"68","author":"Silvinato","year":"2022","journal-title":"Rev. Assoc. Medica Bras."},{"key":"B175","doi-asserted-by":"publisher","first-page":"110367","DOI":"10.1016\/j.pnpbp.2021.110367","article-title":"PPAR\u03b3 receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice","volume":"111","author":"Sonego","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B176","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbi.2018.09.014","article-title":"Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors","volume":"74","author":"Sonego","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"B177","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.euroneuro.2015.02.001","article-title":"\u03949-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption","volume":"25","author":"Stern","year":"2015","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00228-012-1393-4","article-title":"A phase I study to assess the effect of food on the single dose bioavailability of the THC\/CBD oromucosal spray","volume":"69","author":"Stott","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B181","first-page":"119","article-title":"Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects","volume":"53","author":"Strange","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"B182","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0009-3084(00)00189-4","article-title":"2-Arachidonoylglycerol and the cannabinoid receptors","volume":"108","author":"Sugiura","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"B183","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"B185","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1535-7597.2003.03508.x","article-title":"Does serotonin play a role in epilepsy?","volume":"3","author":"Theodore","year":"2003","journal-title":"Epilepsy Curr."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/mp.2013.57","article-title":"Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation","volume":"18","author":"Trifilieff","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B187","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nn1919","article-title":"Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus","volume":"10","author":"Tsetsenis","year":"2007","journal-title":"Nat. Neurosci."},{"key":"B188","first-page":"94","article-title":"Adverse effects of recreational and medical cannabis","volume":"51","author":"Urits","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"B189","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1111\/bph.14380","article-title":"Effects of cannabidiol plus naltrexone on motivation and ethanol consumption","volume":"175","author":"Viudez-Mart\u00ednez","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41401-018-0032-8","article-title":"Cannabidiol does not display drug abuse potential in mice behavior","volume":"40","author":"Viudez-Mart\u00ednez","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"B191","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/adb.12495","article-title":"Cannabidiol reduces ethanol consumption, motivation and relapse in mice","volume":"23","author":"Viudez-Mart\u00ednez","year":"","journal-title":"Addict. Biol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"52908","DOI":"10.1155\/2007\/52908","article-title":"Endocannabinoid system and synaptic plasticity: implications for emotional responses","volume":"2007","author":"Viveros","year":"2007","journal-title":"Neural Plast."},{"key":"B193","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/1673-5374.243719","article-title":"Effects of TRPA1 activation and inhibition on TRPA1 and CGRP expression in dorsal root ganglion neurons","volume":"14","author":"Wang","year":"2019","journal-title":"Neural Regen. Res."},{"key":"B194","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.2174\/1381612822666160822151323","article-title":"Brain imaging studies on the cognitive, pharmacological and neurobiological effects of cannabis in humans: evidence from studies of adult users","volume":"22","author":"Weinstein","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"B195","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41398-019-0534-2","article-title":"Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis","volume":"9","author":"Wilson","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B196","doi-asserted-by":"publisher","first-page":"108736","DOI":"10.1016\/j.neuropharm.2021.108736","article-title":"Mechanisms of endocannabinoid control of synaptic plasticity","volume":"197","author":"Winters","year":"2021","journal-title":"Neuropharmacology"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/npp.2011.17","article-title":"Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study","volume":"36","author":"Winton-Brown","year":"2011","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/bph.12199","article-title":"Cannabidiol attenuates deficits of visuospatial associative memory induced by \u0394(9) tetrahydrocannabinol","volume":"170","author":"Wright","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/brainsci11091211","article-title":"Understanding the modulatory effects of cannabidiol on Alzheimer\u2019s disease","volume":"11","author":"Xiong","year":"2021","journal-title":"Brain Sci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"103202","DOI":"10.1016\/j.etap.2019.103202","article-title":"Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model","volume":"70","author":"Xu","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/1389201020666191202111534","article-title":"The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities","volume":"21","author":"Xu","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbb.2019.05.002","article-title":"Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism","volume":"181","author":"Zieba","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B204","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol. Oxf Engl."},{"key":"B205","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the treatment of psychosis in Parkinson\u2019s disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"J. Psychopharmacol. Oxf Engl."},{"key":"B206","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0269881106060967","article-title":"Cannabidiol monotherapy for treatment-resistant schizophrenia","volume":"20","author":"Zuardi","year":"2006","journal-title":"J. Psychopharmacol. Oxf Engl."},{"key":"B207","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"B208","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacol. Berl."},{"key":"B209","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1328885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T04:11:35Z","timestamp":1705291895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1328885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":209,"alternative-id":["10.3389\/fphar.2023.1328885"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1328885","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"article-number":"1328885"}}